Does vascular access monitoring work?

Area of Science:

• Nephrology
• Vascular Surgery
• Medical Devices

Background:

• Hemodialysis graft survival is often prolonged by preemptive correction of stenosis.
• However, robust evidence from prospective randomized controlled trials (RCTs) confirming this benefit is scarce.
• Existing studies are largely non-randomized or use historical controls.

Purpose of the Study:

• To evaluate the effectiveness of surveillance and intervention strategies in preventing thrombosis and prolonging hemodialysis graft survival.
• To assess the role of blood flow monitoring as a surveillance method.
• To address the controversy surrounding the accuracy of ultrasound dilution in predicting graft thrombosis.

Main Methods:

• Review of existing prospective randomized controlled trials and non-randomized studies.
• Analysis of surveillance methods, focusing on stenosis detection and blood flow monitoring (ultrasound dilution).
• Evaluation of outcomes including graft thrombosis and survival rates.

Main Results:

• Limited RCTs support the benefit of stenosis surveillance and intervention, primarily for new grafts.
• The efficacy of blood flow monitoring (ultrasound dilution) in predicting thrombosis remains controversial.
• No definitive benefit has been established for universal surveillance of all grafts using blood-flow monitoring.

Conclusions:

• While correcting stenosis before thrombosis may enhance graft survival, high-quality evidence from RCTs is lacking.
• The predictive accuracy of blood flow measurements for thrombosis requires further investigation.
• Current evidence does not support the routine implementation of blood-flow monitoring for all hemodialysis grafts.